Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |